# Citius Pharmaceuticals, Inc.: Form 10-K/A for the period ended Sep 30, 2024

- Company: [Citius Pharmaceuticals, Inc.](/companies/ctxr.md) (CIK 1506251)
- Form: 10-K/A
- Filed: 2025-01-27
- Accepted by EDGAR: Jan 27, 2025, 16:13 ET
- Period: 2024-09-30
- Accession: 0001213900-25-006997
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1506251/000121390025006997/ea0228725-10ka1_citius.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1506251/000121390025006997/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1506251/000121390025006997/ea0228725-10ka1_citius.htm

Filed Jan 27, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-006997. Last ingested by Listed: Nov 4, 2026, 17:46 ET. No prices; not investment advice.